Download PDF
1 / Pages

Other users also viewed these articles

The CORCOBIA study: Cut-off points of Alzheimer¿s disease CSF biomarkers in a clinical cohort A. Puig-Pijoan; G. García-Escobar; A. Fernández-Lebrero; R.M. Manero-Borràs; G. Sánchez-Benavides; I. Navalpotro-Gómez; D. Cascales Lahoz; M. Suárez-Calvet; O. Grau-Rivera; A. Boltes Alandí; M.C. Pont-Sunyer; J. Ortiz-Gil; S. Carrillo-Molina; D. López-Villegas; M.T. Abellán-Vidal; M.I. Martínez-Casamitjana; J.J. Hernández-Sánchez; J. Peña-Casanova; J. Roquer; A. Padrós Fluvià; V. Puente-Périz;
10.1016/j.nrleng.2022.05.002
Biomarkers of Alzheimer disease in mild cognitive impairment: Experience in a memory clinic from Latin America R.F. Allegri; P. Chrem Mendez; M.J. Russo; G. Cohen; I. Calandri; J. Campos; F. Nahas; E. Surace; S. Vazquez; G. Sevlever;
Neurologia. 2021;36:201-8
Degenerative dementias: a question of syndrome or disease? A. Robles Bayón;
Neurologia. 2022;37:480-91